Telangana govt proposes a mega biopharma hub at Genome Valley

The proposed facility, to come up with an estimated cost of Rs 60 crore, will be set up through Public Private Partnership in Genome Valley, which is India's first organised cluster for life sciences R&D and clean manufacturing activities.

0
606
Image for representational purpose only!

Hyderabad: Revealing its plans recently, the Telangana government has stated that it proposes to set up India’s first 40,000 square feet Biopharma-Hub at Hyderabad’s Genome Valley, which currently houses over 200 biopharma firms including few top global vaccine makers, at an outlay of Rs 60 crore in public private partnership.

The Biopharma hub aims to provide support to the biopharma research and development activities, featuring a scaleup manufacturing facility and a turnkey incubator/ lab space module.

In a statement, the Telangana government said companies that are in early stage clinical development but lack the requisite expertise and resources to navigate the complexities associated with business planning, cell line development, process development, technology, and/or regulatory and risk assessment, can leverage B-Hub facility to help breakdown roadblocks and improve likelihood of commercial success.

As per the industries minister of Telangana, Mr KT Rama Rao , “With Indian companies aggressively embarking on the global biosimilars opportunity, a biopharma scale-up facility will help them leapfrog in their endeavour, while reducing the time to market.”

“Genome Valley is a very unique cluster and the kind of cutting edge scientific efforts happening in Genome Valley is just unmatchable by any other cluster in India and perhaps Asia,” he added.